Overview
Mihir Shukla is a Hematologist Oncology specialist and a Hematologist practicing medicine in New York, New York.
His clinical expertise encompasses Rosai-Dorfman Disease, Acute Myeloid Leukemia (AML), and Langerhans Cell Histiocytosis.
He is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
550 1st Ave, New York, NY 10016
111 Broadway, New York, NY 10006
240 E 38th St, New York, NY 10016
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
New York Queens Medicine And Surgery, P.C.
Giuseppe Giaccone is a Hematologist Oncology specialist and an Oncologist practicing medicine in Flushing, New York. Dr. Giaccone is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Thymic Epithelial Tumor, Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), and Tissue Biopsy.
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
The Chronic Lymphocytic Leukemia (CLL) Research and Treatment Program has become a landmark for CLL patients worldwide. Dr. Kanti Rai has been involved in diagnosing and treating CLL for almost 40 years and the staging system that bears his name came out of his early breakthrough research. His particular areas of interest are: natural history of CLL, improving prognostic features of this disease and developing newer strategies of therapy which are hypothesis-driven. Dr. Rai is an active member of the International Workshop on CLL (iwCLL) and Dr. Keating s Global CLL Foundation. He is an active member of the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR) and the American Society of Hematology (ASH). In 2006, Dr. Rai served as the President of ASH. He was the recipient of ASCO s David Karnofsky Memorial Award in 2012. In 2013, Dr. Rai was honored with the iwCLL David Galton award. In 2014 he was presented with ASH s Wallace H. Coulter Lifetime Achievement Award. Dr. Rai is the Joel Finkelstein Cancer Foundation Professor of Medicine, and Professor of Molecular Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell School of Medicine and Professor of Medicine at the Feinstein Institute for Medical Research, Manhasset, NY. Dr. Rai is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, and Richter Syndrome. Dr. Rai is board certified in American Board Of Pediatrics.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Alison Moskowitz is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Moskowitz is highly rated in 33 conditions, according to our data. Her clinical expertise encompasses T-Cell Lymphoma, Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Moskowitz is currently accepting new patients.
Frequently Asked Questions about Dr. Mihir A. Shukla
How do I make an appointment with Dr. Mihir A. Shukla?
You can book an appointment with Dr. Mihir A. Shukla by calling their office at 212-263-7300. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Mihir A. Shukla a top-rated expert for Rosai-Dorfman Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mihir A. Shukla is classified as an Experienced expert for Rosai-Dorfman Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Mihir A. Shukla specialize in?
While Dr. Mihir A. Shukla is a Hematology Oncology, they have specific expertise in Rosai-Dorfman Disease, Acute Myeloid Leukemia (AML), and Langerhans Cell Histiocytosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Mihir A. Shukla participate in research or clinical trials?
Yes. Dr. Mihir A. Shukla has published 9 articles and abstracts on conditions like Rosai-Dorfman Disease. You can view a list of Dr. Mihir A. Shukla's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Mihir A. Shukla accept my insurance?
Dr. Mihir A. Shukla accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 212-263-7300 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Myeloid Leukemia (AML)Dr. Shukla isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Langerhans Cell HistiocytosisDr. Shukla isExperienced. Learn about Langerhans Cell Histiocytosis.
- Rosai-Dorfman DiseaseDr. Shukla isExperienced. Learn about Rosai-Dorfman Disease.